Point3 Highly Specialized Product Lineup

Point3 Highly Specialized Product LineupPoint3 専門性の高い製品ラインナップ

As long as needed, we will deliver valuable pharmaceuticals to patients

We have been engaged in the development of new drugs in the three therapeutic areas of internal medicine, obstetrics and gynecology, and urology, as well as the provision of generics, which are also a need of society. We enhance our presence as a specialty pharma company by focusing on the continuous development of new drugs to deliver higher value-added products.

Internal Medicine

We have drugs for gastric and intestinal diseases such as gastric ulcers, gastritis, reflux esophagitis, and inflammatory bowel disease, as well as for hyperlipidemia, hypertension, and endocrine disorders such as thyroid disease. In the thyroid area, we have a large share (96%) of the domestic market.

  • Hepatic encephalopathy agent
    RIFXIMA
    (rifaximin)
  • Antihypertensive agent
    CANDESARTAN
    (candesartan)
  • Hypothyroidism agent
    THYRADIN
    (levothyroxine)

Obstetrics and Gynecology

We contribute to the improvement of women's quality of life by providing oral contraceptives, emergency contraceptives and pharmaceuticals related to menstruation, fertility agents such as ovulation-inducing agents for those who wish to conceive, pharmaceuticals to treat uterine fibroids and endometriosis, and pharmaceuticals for management during pregnancy and childbirth.

  • Uterine fibroids and
    endometriosis agent
    RELUMINA
    (relugolix)
  • Dysmenorrhea agent
    FREWELL
    (norethisterone/
    ethinylestradiol)
  • Emergency
    Contraceptives
    NORLEVO
    (levonorgestrel) 

Urology

We are utilizing the technologies we have cultivated in our traditional hormone products, including agents for prostate cancer, which is increasing every year due to the aging of the population and the westernization of our diet, as well as agents for dysuria and urinary incontinence, and agents for various symptoms caused by low male hormone levels.

  • Endometriosis, uterine fibroids,
    and prostate cancer agent
    LEUPRORELIN
    (leuprorelin)
  • Benign prostatic hyperplasia 
    and prostate cancer agent
    PROSTAL
    (chlormadinone)